A detailed history of Pictet Asset Management Sa transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 11,656 shares of ARWR stock, worth $220,997. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,656
Previous 12,327 5.44%
Holding current value
$220,997
Previous $313,000 32.59%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$25.16 - $41.38 $16,882 - $27,765
-671 Reduced 5.44%
11,656 $415,000
Q1 2023

May 10, 2023

BUY
$23.68 - $38.51 $18,470 - $30,037
780 Added 6.76%
12,327 $313,000
Q4 2022

Feb 13, 2023

BUY
$28.0 - $40.56 $144,452 - $209,249
5,159 Added 80.76%
11,547 $468,000
Q4 2021

Feb 10, 2022

SELL
$58.09 - $82.51 $18.3 Million - $25.9 Million
-314,326 Reduced 98.01%
6,388 $424,000
Q3 2021

Nov 12, 2021

BUY
$58.38 - $84.96 $18.7 Million - $27.2 Million
320,714 New
320,714 $20 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.01B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.